Pacira BioSciences, Inc. (PCRX) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Pacira Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.998 Good day, and thank you for standing by. Welcome to the Q1 2026 00:00:04.998 -- 00:00:09.524 Pacira, excuse me, 2026 Pacira Biosciences, Inc. 00:00:09.524 -- 00:00:14.451 Earnings Conference Call. At this time, all participants are in a listen-only mode. 00:00:14.451 -- 00:00:17.856 After the speaker's presentation, there will be a question and answer session. 00:00:17.856 -- 00:00:23.083 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:23.083 -- 00:00:26.913 You will then hear an automated message advising that your hand is raised. 00:00:26.913 -- 00:00:29.997 To withdraw your question, please press star 11 again. 00:00:29.997 -- 00:00:33.863 Please be advised that today's conference is being recorded. 00:00:33.863 -- 00:00:38.029 I would now like to hand the conference over to your first speaker today, Susan Mesko, 00:00:38.029 -- 00:00:39.991 Head of Investor Relations. Please go ahead. 00:00:39.991 -- 00:00:41.991 Thank 00:00:43.236 -- 00:00:47.802 you. Good afternoon, everyone. Welcome to today's conference call to discuss our first 00:00:47.802 -- 00:00:53.090 quarter 2026 financial results. Joining me are Frank Lee, Chief Executive 00:00:53.090 -- 00:00:58.426 Officer, Brendan Tehan, Chief Commercial Officer, and Sean Cross, Chief Financial 00:00:58.426 -- 00:01:03.430 Officer. Kristen Williams, Chief Administrative Officer and Secretary, Tony 00:01:03.430 -- 00:01:08.635 Molloy, Chief Legal Officer, and Jonathan Slonin, Chief Medical Officer are also 00:01:08.635 -- 00:01:11.397 here for today's question and answer session. 00:01:11.397 -- 00:01:16.202 Before we begin, let me remind you that this call will include forward-looking statements 00:01:16.202 -- 00:01:20.305 subject t...